ArticleMultiple sclerosis and related disorders2022

Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine.

Livnat Brill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.